Comparison of the Effect on Glycemic Control of Biphasic Insulin Aspart 70/30, Biphasic Insulin Aspart 50/50, and Biphasic Insulin Aspart 30/70 All in Combination With Metformin in Subjects With Type 2 Diabetes (the INTENSIMIX Trial).
Phase of Trial: Phase III
Latest Information Update: 07 Jan 2017
At a glance
- Drugs Insulin aspart/insulin protamine aspart (Primary)
- Indications Type 2 diabetes mellitus
- Focus Registrational; Therapeutic Use
- Acronyms INTENSIMIX
- 31 Aug 2018 Biomarkers information updated
- 09 Nov 2012 Planned number of patients changed from 600 to 750 as reported by European Clinical Trials Database.
- 20 May 2009 Patient number changed from 600 to 603 as reported by ClinicalTrials.gov.
Most Recent Events
Table of Contents
- At a glance
- Trial Overview
- Trial Details
- Trial Centres
- Trial History